Drug Repurposing Company focused on neurological rare diseases.
SOM Biotech has raised €7.0M across 1 funding round, most recently a Series A round in Jan 2019. Based in Barcelona, Spain; founded 2009; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2019-01-01 | Series A | €7.0M |
| — |
| View deal → |
